ANGLE is a world leading liquid biopsy company. Our Parsortix® technology enables the capture and harvest of viable circulating tumor cells (CTCs) from patient blood.
The Parsortix® system captures CTCs based on their size, and without antibodies, therefore capturing the full range of cancer cells, including mesenchymal cells and CTC clusters. The enriched CTC fraction can be analysed by a range of downstream techniques including immunofluorescence and molecular methods. The harvested CTCs are alive and can also be cultured.
ANGLE has two clinical service labs (US and UK). The labs employ standardized workflows for analysis of epithelial and mesenchymal CTCs and have the capability to develop custom CTC assays. Our team is highly experienced in supporting clinical research studies.
Parsortix® technology is for Research Use Only. Not for Use in Diagnostic Procedures.
Company’s Keywords:
circulating tumor cells, cancer diagnostic, rare cell separation, cell separation technology, oncology, ctcs, clinical research, medical diagnostics, cancer diagnostics, foetal health, liquid biopsy, medical oncology, drug developments, dna, molecular analysis
<99
<1034000
<1994
Your request has been submitted successfully.
Own or work here?